Allucent Launches Decentralized Clinical Trial Solution


Allucent announced that it has partnered with THREAD to launch Allucent Patient Direct Trials. The new offering brings technology, development, and regulatory expertise to small and emerging biotechnology companies to support them in designing and overseeing customized decentralized clinical trial (DCT) approaches that address their needs.

Allucent Patient Direct Trials leverages this experience to address the needs of many small and emerging biotech companies that may not have the in-house resources required to design and oversee DCTs. Working with THREAD, Allucent's team of regulatory and product development consultants can guide sponsors in determining the most effective and efficient digital strategies for remote engagement and data collection for their studies.


Allucent Launches Decentralized Clinical Trial Solution at 2023 World Orphan Drug Congress. (2023, May 23). Cision PR Newswire.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.